Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.32 |
| ▸ | RXRA | P19793 | 1/20 | 0.32 |
| ▸ | RXRB | P28702 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.32 |
| ▸ | METAP2 | P50579 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21534252 | 0.97 | L3MBTL1 (0.40) | L3MBTL1KDM4EATMMAPK14KMT2A | |
| SCHEMBL21534301 | 0.94 | KDM4E (0.36) | L3MBTL1KDM4EATM | |
| SCHEMBL21534292 | 0.93 | L3MBTL1 (0.43) | L3MBTL1KDM4EATMMAPK14RXRA | |
| SCHEMBL21534263 | 0.93 | L3MBTL1 (0.43) | L3MBTL1KDM4EATMMAPK14RXRA | |
| SCHEMBL21534261 | 0.93 | L3MBTL1 (0.45) | L3MBTL1KDM4EATMRXRARXRB | |
| SCHEMBL21534335 | 0.93 | L3MBTL1 (0.45) | L3MBTL1KDM4EATMRXRARXRB | |
| SCHEMBL24948945 | 0.92 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMMAPK14RXRA | |
| SCHEMBL24948943 | 0.92 | L3MBTL1 (0.46) | L3MBTL1KDM4EATMMAPK14KMT2A | |
| SCHEMBL21038517 | 0.91 | L3MBTL1 (0.41) | L3MBTL1KDM4EATMMAPK14RXRA | |
| SCHEMBL20738401 | 0.91 | KDM4E (0.45) | L3MBTL1KDM4EATMRXRARXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190334096-A1 | DIAMINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-10-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190334096-A1 | DIAMINE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | AOC1, DDT, DDC | L3MBTL1 1164/4885KDM4E 614/4885ATM 2546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.